Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders | MicrobiomeTrials← Back to trialsNCT06333652
Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2027-04-01Est. Completion: 2028-12-31
Enrollment target: 14 participants Locations- Mayo Clinic Minnesota, Rochester, Minnesota, United States
Other microbiome trials you might be interested in
Malaria
Malaria caused by Plasmodium falciparum continues to be a global problem with devastating consequences. A greater unders…
Bamako, Mali
Hypertensive Disorder of PregnancyPreeclampsia
The purpose of this study is to compare latency (prolongation of pregnancy from diagnosis till delivery) in patients wit…
Columbus, United StatesEst. completion Dec 2027
Hypertensive Disorders of PregnancyPreeclampsiaGestational Hypertension
The objective is to conduct a double-blinded randomized controlled trial of atorvastatin vs. placebo among postpartum in…
Columbus, United StatesEst. completion Sep 15, 2027